Arkolith/Insider Trading/MIST/Form 4

Muller Lorenz

Chief Commercial OfficerMilestone Pharmaceuticals Inc. (MIST) · full profile →Form 4 · filed Dec 11, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 9, 2025Gift(G)25K—$0150K

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001771207-25-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML